AVILEX PHARMA ApS — Credit Rating and Financial Key Figures
CVR number: 34896828
Ole Maaløes Vej 3, 2200 København N
http://www.avilexpharma.com
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 45 479.00 | ||||
| Other operating income | 7 309.70 | 1 987.00 | |||
| Costs of manufacturing | -9 540.70 | ||||
| Gross profit | -2 231.00 | 1 987.00 | 45 479.00 | ||
| Costs of management | - 901.65 | -3 200.00 | -7 255.00 | -1 673.00 | - 627.00 |
| Other operating expenses | -7 472.00 | -3 366.00 | -4 361.00 | -4 176.00 | |
| EBIT | -3 132.65 | -8 685.00 | 34 858.00 | -6 034.00 | -4 803.00 |
| Other financial income | 84.22 | 77.00 | 3 979.00 | 88.00 | 1 896.00 |
| Other financial expenses | - 929.25 | -1 922.00 | -2 176.00 | -2 754.00 | -1 828.00 |
| Pre-tax profit | -3 977.68 | -10 530.00 | 36 661.00 | -8 700.00 | -4 735.00 |
| Income taxes | 935.98 | 3 214.00 | -8 061.00 | 1 944.00 | 307.00 |
| Net earnings | -3 041.70 | -7 316.00 | 28 600.00 | -6 756.00 | -4 428.00 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Prepayments and accrued income | 59.31 | 64.00 | |||
| Current other receivables | 300.32 | 605.00 | 362.00 | 516.00 | 164.00 |
| Current deferred tax assets | 1 506.30 | 4 437.00 | 1 407.00 | 2 780.00 | 1 328.00 |
| Short term receivables total | 1 865.93 | 5 106.00 | 1 769.00 | 3 296.00 | 1 492.00 |
| Cash and bank deposits | 7 509.06 | 598.00 | 29 827.00 | 24 579.00 | 20 067.00 |
| Cash and cash equivalents | 7 509.06 | 598.00 | 29 827.00 | 24 579.00 | 20 067.00 |
| Balance sheet total (assets) | 9 374.99 | 5 704.00 | 31 596.00 | 27 875.00 | 21 559.00 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 408.69 | 409.00 | 470.00 | 470.00 | 470.00 |
| Retained earnings | -16 016.27 | -21 144.00 | -24 153.00 | 4 447.00 | -2 309.00 |
| Profit of the financial year | -3 041.70 | -7 316.00 | 28 600.00 | -6 756.00 | -4 428.00 |
| Shareholders equity total | -18 649.29 | -28 051.00 | 4 917.00 | -1 839.00 | -6 267.00 |
| Non-current loans from credit institutions | 25 584.30 | 25 867.00 | 19 963.00 | 22 007.00 | 23 829.00 |
| Non-current other liabilities | 5 110.00 | 4 320.00 | |||
| Non-current liabilities total | 25 584.30 | 30 977.00 | 24 283.00 | 22 007.00 | 23 829.00 |
| Current loans from credit institutions | 31.27 | 1.00 | 24.00 | 4 967.00 | 3 513.00 |
| Current trade creditors | 1 278.72 | 2 567.00 | 2 121.00 | 2 422.00 | 223.00 |
| Current owed to group member | 570.32 | ||||
| Other non-interest bearing current liabilities | 559.66 | 210.00 | 251.00 | 318.00 | 261.00 |
| Current liabilities total | 2 439.98 | 2 778.00 | 2 396.00 | 7 707.00 | 3 997.00 |
| Balance sheet total (liabilities) | 9 374.99 | 5 704.00 | 31 596.00 | 27 875.00 | 21 559.00 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.